Qube Research & Technologies LTD Idera Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.01 - $1.58 $14,248 - $22,289	-14,107 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.23 - $5.98 $68,904 - $334,999	-56,020 Reduced 79.88%	14,107 $18,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $5.18 $222,846 - $552,317	-106,625 Reduced 60.32%	70,127 $257,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.68 $262,019 - $410,651	153,228 Added 651.37%	176,752 $378,000
Q2 2020 Aug 14, 2020	BUY	$1.23 - $2.12 $28,934 - $49,870	23,524 New	23,524 $42,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.